biguanides has been researched along with Pulmonary Fibrosis in 1 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, CM | 1 |
| Kim, HY | 1 |
| Jeon, D | 1 |
| Shin, YJ | 1 |
| Kim, IH | 1 |
| Choi, SJ | 1 |
| Kim, KC | 1 |
| Lee, K | 1 |
| Kim, SH | 1 |
| Kim, MS | 1 |
1 other study available for biguanides and Pulmonary Fibrosis
| Article | Year |
|---|---|
Anti-fibrotic effect of pycnogenol® in a polyhexamethylene guanidine-treated mouse model.
Topics: Animals; Anti-Inflammatory Agents; Biguanides; Disease Models, Animal; Flavonoids; Inflammation; Mal | 2022 |